Chief Scientific Officer
Founder and CSO of Virosome Biologicals BV, which was acquired by Mymetics in April 2009. Previous roles included Director of Vaccine Research at Crucell, Director of Vaccine Research at Algonomics, Professor of Biochemistry and Molecular Biology at the University of Toulouse and Assistant Professor of Biochemistry at the University of Basel. Has been a biotechnology consultant for a range of venture capital firms. Dr. Stegmann is the author of over fifty scientific publications and books and has filed/obtained 12 patent applications. Dr. Stegmann holds a Ph.D. in biochemistry from the University of Groningen, the Netherlands, focused on virosomes and holds a post-doctorate from Yale University where he focused on the influenza virus.